Minhdan Nguyen, PA-C

Minhdan Nguyen practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Minhdan Nguyen's NPI, 1689009557, was assigned on September 10, 2013. Minhdan Nguyen holds California license 53041.

Minhdan Nguyen's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Minhdan Nguyen's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is Saint John's Physician Partners. Dmand AI also links Minhdan Nguyen to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Minhdan Nguyen practices. Vendor and product names are available with a free account.

Physician assistant is Minhdan Nguyen's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Minhdan Nguyen is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Minhdan Nguyen's licenses on file in 2 states: California and North Carolina.

CMS data shows 12 Medicare services from Minhdan Nguyen across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $1,228 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 19 Medicare patients who saw Minhdan Nguyen in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Minhdan Nguyen's median patient age at 17, with 39% women.

In 2024, Minhdan Nguyen wrote 141 Medicare Part D claims for 45 patients. 97% of them were for generic drugs. CMS names the drug for 53 of them, across 3 drugs with 11 or more claims each, at $2,655 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Minhdan Nguyen for performance year 2024, reported as part of a group.

CMS Open Payments shows 16 general payments to Minhdan Nguyen from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $295.

Minhdan Nguyen is a member of AAPA.